| Rembrandt provides clinical and functional genomics data from clinical trials involving
patients suffering from Gliomas as a public service by the National Cancer Institute (NCI) to
foster the rapid dissemination of information to the scientific community and the public. All data may be subject to copyright provisions.
You may browse, download, and use the data for non-commercial, scientific and
educational purposes. However, you may encounter documents or portions of documents contributed by
private institutions or organizations. Other parties may retain all rights to publish or produce these
documents. Commercial use of the documents on this site may be protected under United States and foreign
copyright laws. In addition, some of the data may be the subject of patent applications or issued patents,
and you may need to seek a license for its commercial use. |